Daniel Rosenberg's questions to WELL Health Technologies Corp (WHTCF) leadership • Q4 2024
Question
Daniel Rosenberg of Paradigm Capital asked about operational changes at Circle Medical following the revenue issue, its impact on growth and valuation, the drivers behind the strong 2025 guidance, and which WELLSTAR products have the best potential for international scaling.
Answer
Hamed Shahbazi, Chairman and CEO, stated that while Circle's short-term growth may slow during a compliance review, he doesn't anticipate a long-term impact on value. He attributed the strong 2025 guidance to high organic growth and a deep M&A pipeline, which will be fueled by future liquidity from U.S. asset sales. For global expansion, Shahbazi highlighted the OceanMD product suite as having exceptional international potential, which can now be leveraged through Orion Health's established global channels.